Premium
Equity incentive plans and R&D investment manipulation: evidence from China
Author(s) -
Zhang Weidong,
Hu Pengbo,
Wang Jenny J.,
Li Zeyu,
Zheng Hongrui,
Gao Xue
Publication year - 2022
Publication title -
accounting and finance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 49
eISSN - 1467-629X
pISSN - 0810-5391
DOI - 10.1111/acfi.12919
Subject(s) - earnings management , accrual , incentive , equity (law) , business , earnings response coefficient , earnings , accounting , equity risk , finance , economics , private equity , microeconomics , political science , law
This paper examines the issue of earning management in companies with equity incentives from two dimensions: management manipulation of the intensity of R&D and accounting treatment by using a sample of Shanghai and Shenzhen listed companies in China from 2014 to 2019. We find that in order to depress the benchmarks and exercise prices for the performance appraisal of the equity incentive covenants, managers not only conduct accrual earnings management by expensing R&D expenditure but also increase the intensity of R&D investment for real earnings management. We also find that companies with equity incentives where managers have more power are more inclined to opt for the more concealed means of real earnings management and try to avoid accrual earnings management, which may entail higher regulatory costs and greater litigation risk with tightening accounting regulations. Our findings contribute to expanding the literature on earnings management of companies with equity incentives and provide empirical evidence for regulators to implement ‘precision regulation’ on equity incentives and earnings management.